ZA965318B - Camptothecin beta-hydrolactone compounds - Google Patents
Camptothecin beta-hydrolactone compoundsInfo
- Publication number
- ZA965318B ZA965318B ZA965318A ZA965318A ZA965318B ZA 965318 B ZA965318 B ZA 965318B ZA 965318 A ZA965318 A ZA 965318A ZA 965318 A ZA965318 A ZA 965318A ZA 965318 B ZA965318 B ZA 965318B
- Authority
- ZA
- South Africa
- Prior art keywords
- hydrolactone
- camptothecin
- beta
- compounds
- hydrolactone compounds
- Prior art date
Links
- KLWPJMFMVPTNCC-UHFFFAOYSA-N Camptothecin Natural products CCC1(O)C(=O)OCC2=C1C=C3C4Nc5ccccc5C=C4CN3C2=O KLWPJMFMVPTNCC-UHFFFAOYSA-N 0.000 title 1
- VSJKWCGYPAHWDS-FQEVSTJZSA-N camptothecin Chemical compound C1=CC=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)[C@]5(O)CC)C4=NC2=C1 VSJKWCGYPAHWDS-FQEVSTJZSA-N 0.000 title 1
- 229940127093 camptothecin Drugs 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- VSJKWCGYPAHWDS-UHFFFAOYSA-N dl-camptothecin Natural products C1=CC=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)C5(O)CC)C4=NC2=C1 VSJKWCGYPAHWDS-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9512670.2A GB9512670D0 (en) | 1995-06-21 | 1995-06-21 | Camptothecin analogues |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA965318B true ZA965318B (en) | 1997-01-24 |
Family
ID=10776457
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA965318A ZA965318B (en) | 1995-06-21 | 1996-06-21 | Camptothecin beta-hydrolactone compounds |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US5981542A (xx) |
| CN (1) | CN1227254C (xx) |
| GB (1) | GB9512670D0 (xx) |
| UA (1) | UA63891C2 (xx) |
| ZA (1) | ZA965318B (xx) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2790261B1 (fr) * | 1999-02-26 | 2004-09-10 | Sod Conseils Rech Applic | Nouveaux analogues optiquement purs de la camptothecine et leurs procedes de preparation |
| ATE216998T1 (de) * | 1999-03-09 | 2002-05-15 | Sigma Tau Ind Farmaceuti | Camptothecin-derivate mit antitumor-wirkung |
| US6207832B1 (en) * | 1999-04-09 | 2001-03-27 | University Of Pittsburgh | Camptothecin analogs and methods of preparation thereof |
| AU775373B2 (en) | 1999-10-01 | 2004-07-29 | Immunogen, Inc. | Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents |
| US6503894B1 (en) | 2000-08-30 | 2003-01-07 | Unimed Pharmaceuticals, Inc. | Pharmaceutical composition and method for treating hypogonadism |
| US6723853B2 (en) * | 2001-08-27 | 2004-04-20 | University Of Pittsburgh | Intermediates and methods of preparation of intermediates in the enantiomeric synthesis of (20R)homocamptothecins and the enantiomeric synthesis of (20R)homocamptothecins |
| US20040072810A1 (en) | 2001-11-07 | 2004-04-15 | Besins International Belgique | Pharmaceutical composition in the form of a gel or a solution based on dihydrotestosterone, process for preparing it and uses thereof |
| PL2450041T3 (pl) | 2005-10-12 | 2019-02-28 | Unimed Pharmaceuticals, Llc | Ulepszony żel zawierający testosteron do zastosowania do leczenia hipogonadyzmu |
| US7875602B2 (en) * | 2005-10-21 | 2011-01-25 | Sutter West Bay Hospitals | Camptothecin derivatives as chemoradiosensitizing agents |
| PL2007386T3 (pl) * | 2006-04-19 | 2013-01-31 | Crown Bioscience Inc | Analog kamptotecyny z nowym obróconym pierścieniem E z trwałym ugrupowaniem laktonu i sposoby jego wytwarzania i stosowania |
| CN102746314B (zh) * | 2011-04-18 | 2016-07-06 | 华东师范大学 | 含有稳定7元内酯环的喜树碱类化合物、制备方法和用途 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5391745A (en) * | 1992-07-23 | 1995-02-21 | Sloan-Kettering Institute For Cancer Research | Methods of preparation of camptothecin analogs |
-
1995
- 1995-06-21 GB GBGB9512670.2A patent/GB9512670D0/en active Pending
-
1996
- 1996-06-21 ZA ZA965318A patent/ZA965318B/xx unknown
- 1996-06-21 UA UA98010316A patent/UA63891C2/uk unknown
- 1996-06-21 CN CNB021504547A patent/CN1227254C/zh not_active Expired - Fee Related
- 1996-06-21 US US08/973,561 patent/US5981542A/en not_active Expired - Fee Related
-
1999
- 1999-06-04 US US09/325,913 patent/US6313135B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US6313135B1 (en) | 2001-11-06 |
| CN1227254C (zh) | 2005-11-16 |
| UA63891C2 (en) | 2004-02-16 |
| US5981542A (en) | 1999-11-09 |
| GB9512670D0 (en) | 1995-08-23 |
| CN1432571A (zh) | 2003-07-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB9508810D0 (en) | Compounds | |
| GB9500691D0 (en) | Compounds | |
| ZA965318B (en) | Camptothecin beta-hydrolactone compounds | |
| GB9504910D0 (en) | Compounds | |
| GB9512129D0 (en) | Compounds | |
| GB9504948D0 (en) | Compounds | |
| GB9502540D0 (en) | Compounds | |
| SI0826688T1 (en) | Pentacyclic compounds | |
| GB9502784D0 (en) | Compounds | |
| GB9504907D0 (en) | Compounds | |
| GB9507040D0 (en) | Compounds | |
| GB9502782D0 (en) | Compounds | |
| GB9506703D0 (en) | Compounds | |
| GB9507313D0 (en) | Compounds | |
| GB9506169D0 (en) | Compounds | |
| GB9507692D0 (en) | Compounds | |
| GB9507693D0 (en) | Compounds | |
| GB9508009D0 (en) | Compounds | |
| GB9503211D0 (en) | Compounds | |
| GB9508686D0 (en) | Compounds | |
| GB9501581D0 (en) | Compounds | |
| GB9504190D0 (en) | Compounds | |
| GB9508874D0 (en) | Compounds | |
| GB9509403D0 (en) | Compounds | |
| GB9501357D0 (en) | Compounds |